EGFR and lung adenocarcinoma: An increase in A3B and a decrease in UNG protein levels were detected in EGFR TKI-treated tumor tissues from three distinct oncogenic EGFR-driven CDX models of human lung adenocarcinoma (Extended Data Fig. 7a–f).